Ethyl 2-(2-(2-(4-chlorophenoxy)phenyl)-N-methylacetamido)acetate, 97%, 100mg

5-chloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-3-one, 95.0%, 1g

2-(Bicyclo[1.1.1]pentan-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 50mg

1,2,5-Tribromo-3-isopropylbenzene, 98%, 500mg

Vinylpentamethyldisiloxane, 99%, 25g

1-Methylpiperidin-4-amine, 95.0%, 500g

tert-Butyl 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydropyridine-1(2H)-carboxylate, 95.0%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(3-carbamoylphenyl)propanoic acid, 97%, 250mg

(S)-tert-Butyl 6-amino-2-((tert-butoxycarbonyl)amino)hexanoate, 95.0%, 250mg

Bromoform (stabilized with 2-Methyl-2-butene) [for Spectrophotometry]>99.0%(GC)100mL

3,5-Dihydroxybenzamide, 97.0%, 1g

Benzyl (R)-2-((tert-butoxycarbonyl)amino)-3,3-diphenylpropanoate, 98%, 5g

Entonnoir à filtre fritté 1000 ml, 2 (40 – 100 μm), 1 pièce